V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated])
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]), covering 2025-11-18 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002) [Phase 2]